The U.S. Department of Transportation (USDOT) has issued a definitive memo confirming that the federal rescheduling of marijuana will not alter drug testing protocols for the nation's transportation workforce. This clarification, updated on May 15, 2026, follows the Justice Department’s April move to shift cannabis from Schedule I to Schedule III, a transition that many workers hoped would signal a shift in workplace enforcement.
For the approximately 3.5 million commercial drivers, as well as pilots and bus operators, the federal stance remains rigid: "Marijuana use is not compatible with safety-sensitive functions." The USDOT emphasized that while the rescheduling may impact research and pharmaceutical development, it does not move the needle for those behind the wheel or in the cockpit.
The "FDA Approval" Barrier
The memo specifically addresses the role of Medical Review Officers (MROs) in the testing process. Under federal regulations, an MRO can only flip a positive drug test to "negative" if there is a legitimate medical explanation. However, the USDOT maintains that state-dispensed marijuana does not meet this threshold because it lacks FDA approval.
Without an FDA stamp, a substance cannot be legally prescribed under federal guidelines. Consequently, a doctor’s recommendation for medical marijuana is viewed as a certification rather than a valid prescription, providing no protection for workers subject to federal testing.
| Evidence Type | Status Under USDOT Rules |
|---|---|
| State-issued Medical Card | Invalid Explanation |
| Physician Certification | Invalid Explanation |
| Dispensary Receipts | Invalid Explanation |
| FDA-Approved Cannabis Drugs | Valid (with valid prescription) |
The takeaway for safety-sensitive employees is clear: the only cannabis products that clear a DOT test are those that are FDA-approved and accompanied by a traditional prescription. For the millions of workers governed by 49 CFR § 40.137(a), the "Invisible Crisis" of potential job loss due to state-legal medical use remains a stark reality despite federal rescheduling.
